Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.224 SEK | +1.82% | -3.45% | -55.56% |
22/04 | Lipidor AB Postpones the Publication of Annual Report for 2023 | CI |
21/03 | Lipidor AB Announces Approval for Start of Phase III Clinical Trial of Psoriasis Candidate AKP02G2 | CI |
- Stock Market
- Equities
- LIPI Stock
- News Lipidor AB
- MarketScreener Editorial Features